Matthew Kebel has 10+ years of experience advising healthcare technology, tech-enabled, and services clients on M&A transactions and private/public capital raises. Matt focuses on software/SaaS, marketing, media, data/analytics, and services companies across the healthcare sector. Prior to joining Canaccord Genuity, Matt was a healthcare and technology investment banker at Teneo Capital, Pacific Crest Securities, and Morgan Keegan.
Matt graduated with a B.S.B.A in Finance and Accounting, Magna Cum Laude, from the Questrom School of Business at Boston University.
Selected Transactions
-
United Language Group
Financial Advisor to United Language Group on its Sale to Propio
-
Sam Brown
Financial Advisor to Sam Brown Inc. on its Sale to Blue Matter
-
PharmaForceIQ
Financial Advisor to PharmaForceIQ on its Significant Investment from Eir Partners
-
Adfire Health
Financial Advisor to Adfire Health on its Sale to Health Union
-
Jumo Health
Financial Advisor to Jumo Health on its Investment from Falfurrias Management Partners
-
US$968m
Waystar
Co-Manager (IPO)
-
SPM Group
Financial Advisor to SPM Group on its Sale to Unlock Health
-
Kantar
Financial Advisor to Kantar on the Sale of its Healthcare Vertical Business
-
TI Health
Financial Advisor to TI Health on its Sale to Real Chemistry
